Cargando…
Persistence, adherence, and medication-taking behavior in women with postmenopausal osteoporosis receiving denosumab in routine practice in Germany, Austria, Greece, and Belgium: 12-month results from a European non-interventional study
SUMMARY: Persistence with and adherence to osteoporosis therapy are critical for fracture reduction. This non-interventional study is evaluating medication-taking behavior of women with postmenopausal osteoporosis (PMO) receiving denosumab in Germany, Austria, Greece, and Belgium. Patients were repr...
Autores principales: | Hadji, P., Papaioannou, N., Gielen, E., Feudjo Tepie, M., Zhang, E., Frieling, I., Geusens, P., Makras, P., Resch, H., Möller, G., Kalouche-Khalil, L., Fahrleitner-Pammer, A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer London
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4575374/ https://www.ncbi.nlm.nih.gov/pubmed/26018090 http://dx.doi.org/10.1007/s00198-015-3164-4 |
Ejemplares similares
-
Factors associated with high 24-month persistence with denosumab: results of a real-world, non-interventional study of women with postmenopausal osteoporosis in Germany, Austria, Greece, and Belgium
por: Fahrleitner-Pammer, A., et al.
Publicado: (2017) -
Emerging treatments for postmenopausal osteoporosis – focus on denosumab
por: Geusens, Piet
Publicado: (2009) -
Effects of Long-Term Denosumab on Bone Histomorphometry and Mineralization in Women With Postmenopausal Osteoporosis
por: Dempster, David W, et al.
Publicado: (2018) -
Real-world Management of Women with Postmenopausal Osteoporosis Treated with Denosumab: A Prospective Observational Study in the Czech Republic and Slovakia
por: Růžičková, Olga, et al.
Publicado: (2018) -
Persistence and compliance with osteoporosis therapies among postmenopausal women in the UK Clinical Practice Research Datalink
por: Morley, J., et al.
Publicado: (2019)